Latest updates for Tgtx
Fresh curated links around TGTX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors
- Why is TG Therapeutics stock rallying today?
- PTC’s $211M bid wins Sangamo auction, teeing up ‘special opportunity’ to enter Fabry market
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
PTC’s $211M bid wins Sangamo auction, teeing up ‘special opportunity’ to enter Fabry market
PTC Therapeutics has struck a deal to buy Sangamo Therapeutics’ Fabry disease program for $111 million upfront, outbidding Astellas and TerSera Therapeutics for the near-approval g...
TPG RE Finance Trust, Inc. 2026 Q2 - Results - Earnings Call Presentation
MGX Resources Limited (MTGRY) Q4 2026 Earnings Call Transcript
Join TransCode Therapeutics' Live Investor Webinar: Advancing a Multi-Platform Oncology Pipeline Targeting Metastatic Ca...
Learn how TransCode Therapeutics is advancing RNA therapeutics, cancer vaccines, and immuno-oncology programs designed to address advanced and metastatic cancersManagement to discu...
Structure Therapeutics Inc. (GPCR) Discusses Positive Clinical Data Updates for Oral Small Molecule Amylin and GLP-1 Pro...
Taysha outlines REVEAL 6-month interim analysis and FDA feedback in H1 2027 while targeting PPQ completion in Q4 2026
Tolerance Bio jumps into phase 2 with $260M deal for thymus-targeting fusion protein
Tolerance Bio has vaulted into the clinic by agreeing to pay NeoImmuneTech up to $260 million for rights to a fusion protein in certain thymus-related indications in the Americas a...
Toyoda Gosei Co., Ltd. 2027 Q1 - Results - Earnings Call Presentation
Geron (GERN) Q2 2026 Earnings Call Transcript
RYTELO demand grew 5% as prescribing accounts hit 1,575 since launch.
argenx: Upgrading To Buy, The VYVGART Growth Cycle Has Further To Go
<
What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near
Stuart Naylor's 4% portfolio reduction follows an 89% one-year stock surge, executed under a pre-scheduled Rule 10b5-1 trading plan adopted in December 2025.
AGC and Neusignal Therapeutics Collaborate on the Development of Alzheimer's Disease Drug Candidate “NTX-083”
AGC Inc. (Headquarters: Tokyo; President: Yoshinori Hirai; hereinafter “AGC”) highlights its end-to-end support capabilities as a small-molecule pharmaceutical CDMO as demonstrated...
PTC Therapeutics’ $211M Bid Wins Bankruptcy Auction for Sangamo Gene Therapy
Sangamo Therapeutics filed for Chapter 11 bankruptcy in June after its search for strategic alternatives failed to find a path forward for the company. PTC Therapeutics’ auction wi...
Argenx jumps on Phase 3 data for blockbuster Vyvgart
The latest results give investors confidence in the drug's ability to be approved in another indication for which there are no approved treatments.
Tongdao Liepin Group 2026 Q2 - Results - Earnings Call Presentation
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.